Clinical Trials Browser

Phase 2 × Salivary Gland Neoplasms × Imatinib Mesylate × Clear all

NCT00045669 2019-02-15

Imatinib Mesylate in Treating Patients With Salivary Gland Cancer

Phase 2 Completed

Head and Neck Neoplasms, Salivary Gland Neoplasms